Impact of sphingomyelin levels on coronary heart disease and left ventricular systolic function in humans.
about
Sphingolipid signaling in metabolic disordersPlasma metabolomics reveal alterations of sphingo- and glycerophospholipid levels in non-diabetic carriers of the transcription factor 7-like 2 polymorphism rs7903146Altered levels of serum sphingomyelin and ceramide containing distinct acyl chains in young obese adults.Serum lipid feature and potential biomarkers of lethal ventricular tachyarrhythmia (LVTA) induced by myocardial ion channel diseases: a rat model study.
P2860
Impact of sphingomyelin levels on coronary heart disease and left ventricular systolic function in humans.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Impact of sphingomyelin levels ...... r systolic function in humans.
@ast
Impact of sphingomyelin levels ...... r systolic function in humans.
@en
type
label
Impact of sphingomyelin levels ...... r systolic function in humans.
@ast
Impact of sphingomyelin levels ...... r systolic function in humans.
@en
prefLabel
Impact of sphingomyelin levels ...... r systolic function in humans.
@ast
Impact of sphingomyelin levels ...... r systolic function in humans.
@en
P2093
P2860
P356
P1476
Impact of sphingomyelin levels ...... r systolic function in humans.
@en
P2093
Jason M Lazar
Xian-Cheng Jiang
Xueying Chen
Yunzeng Zou
P2860
P2888
P356
10.1186/1743-7075-8-25
P577
2011-04-26T00:00:00Z
P5875
P6179
1013571297